ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,400Medicare Part D Prescriptions Filled, Including Refills

Rank: 338 out of 2035

$480K Total Retail Price of All Prescriptions

Rank: 332 out of 2035

218 Patients Receiving at Least One Drug in Part D
30%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

29% of this provider’s 218 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

42% of this provider’s 218 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

0% of this provider’s 1,851 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 591 118 S3 1 2
LISINOPRIL 226 63 2 3
SIMVASTATIN 218 53 3 1
LEVOTHYROXINE SODIUM 216 90 4 4
OMEPRAZOLE 214 47 5 5
ATENOLOL 213 105 6 10
CARISOPRODOL 187 0 R 7 57
OXYCODONE HCL 168 22 S2 8 62
MORPHINE SULFATE ER 162 0 S2 9 86
FUROSEMIDE 149 84 10 7
FLUTICASONE PROPIONATE 132 16 11 29
PROAIR HFA 131 23 12 31
METOPROLOL TARTRATE 125 55 13 8
HYDROCHLOROTHIAZIDE 123 29 14 12
OXYCODONE HCL-ACETAMINOPHEN 109 0 S2 15 127
TAMSULOSIN HCL 107 53 16 25
AMLODIPINE BESYLATE 97 62 17 6
ZOLPIDEM TARTRATE 96 34 18 21
GABAPENTIN 87 19 19 14
METFORMIN HCL 81 28 20 9
VENLAFAXINE HCL ER 79 0 21 130
KLOR-CON M20 78 53 22 73
OPANA ER 69 0 S2 23 172
MELOXICAM 64 0 24 56
CYCLOBENZAPRINE HCL 63 0 R 25 64
ENALAPRIL MALEATE 62 33 26 60
TRAZODONE HCL 62 0 26 50
CYMBALTA 62 0 26 59
AMITRIPTYLINE HCL 61 0 R 29 101
NAPROXEN 60 0 30 92
IBUPROFEN 59 0 31 43
POTASSIUM CHLORIDE 55 12 32 18
OXYCONTIN 55 0 S2 32 152
LANTUS 54 11 34 40
LYRICA 52 0 35 89
VENTOLIN HFA 51 13 36 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 1, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.